TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bionomen AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
17,050
|
8,893
|
7,931 |
| Financial expenses |
6
|
6
|
9 |
| Earnings before taxes |
3,055
|
1,129
|
-50 |
| EBITDA |
3,061
|
1,141
|
-35 |
| Total assets |
5,043
|
3,235
|
5,047 |
| Current assets |
5,013
|
3,194
|
5,032 |
| Current liabilities |
1,029
|
1,786
|
1,889 |
| Equity capital |
3,750
|
1,339
|
3,048 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
2
|
2
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
74.4%
|
41.4%
|
60.4% |
| Turnover per employee |
8,525
|
4,446
|
2,644 |
| Profit as a percentage of turnover |
17.9%
|
12.7%
|
-0.6% |
| Return on assets (ROA) |
60.7%
|
35.1%
|
-0.8% |
| Current ratio |
487.2%
|
178.8%
|
266.4% |
| Return on equity (ROE) |
81.5%
|
84.3%
|
-1.6% |
| Change turnover |
8,157
|
962
|
486 |
| Change turnover % |
92%
|
12%
|
7% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
0%
|
-33%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.